Perioperative Management of Patient with Systemic Mastocytosis Going for Total Thyroidectomy

Systemic mastocytosis (SM) is a rare disorder affecting 1 in 10,000 individuals, characterised by abnormal mast cell proliferation in extra-cutaneous organs, resulting in a variety of presentations ranging from mild asymptomatic disease to life-threatening tissue-destructive disease. Severe anaphyl...

Full description

Saved in:
Bibliographic Details
Main Authors: Ammar AlShaker, Saud Al-Rasheedi, Yousef Al-Jebrin, Munira Al-Masaad, Nawaf M. Al-Mutairi
Format: Article
Language:English
Published: Riyadh Second Health Cluster Research Center, King Fahad Medical City (KFMC) 2025-01-01
Series:The Journal of Medicine, Law & Public Health
Subjects:
Online Access:https://jmlph.net/index.php/jmlph/article/view/183
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Systemic mastocytosis (SM) is a rare disorder affecting 1 in 10,000 individuals, characterised by abnormal mast cell proliferation in extra-cutaneous organs, resulting in a variety of presentations ranging from mild asymptomatic disease to life-threatening tissue-destructive disease. Severe anaphylaxis caused by the release of histamine from mast cells can lead to poor postoperative outcomes, especially during general anaesthesia, as the severe manifestations of anaphylaxis, such as cardiovascular collapse and bronchospasm, may potentially be the first symptoms to present. In this case report, we describe the perioperative and intraoperative management of a 70-year-old female with SM, undergoing total thyroidectomy.
ISSN:2788-9815
2788-791X